FDA Inspection 1122292 — Northwestern Medicine Central DuPage Hospital
The FDA completed an inspection of Northwestern Medicine Central DuPage Hospital on February 4, 2020 in Winfield, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 4, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Winfield, IL (United States)